2018
DOI: 10.1136/bmjebm-2018-111115
|View full text |Cite
|
Sign up to set email alerts
|

Inclusion and exclusion criteria and the problem of describing homogeneity of study populations in clinical trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
16
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 13 publications
(17 citation statements)
references
References 9 publications
1
16
0
Order By: Relevance
“…A total of 67% of the articles report exclusion criteria. This is consistent with previous reviews that demonstrated exclusion criteria defined in 69 out of 101 selected articles (Porzsolt et al, 2019). The importance of correctly defining exclusion criteria in clinical trials lies in integrating characteristics of subjects prone to lose during intervention or follow-up for various reasons, which, if not applied correctly, could increase the risk of both adverse events and biased results (Patino & Ferreira, 2018).…”
Section: What Was Already Known and Contrasted With The Findings Of This Review?supporting
confidence: 88%
“…A total of 67% of the articles report exclusion criteria. This is consistent with previous reviews that demonstrated exclusion criteria defined in 69 out of 101 selected articles (Porzsolt et al, 2019). The importance of correctly defining exclusion criteria in clinical trials lies in integrating characteristics of subjects prone to lose during intervention or follow-up for various reasons, which, if not applied correctly, could increase the risk of both adverse events and biased results (Patino & Ferreira, 2018).…”
Section: What Was Already Known and Contrasted With The Findings Of This Review?supporting
confidence: 88%
“…These data indicate: 1) although it is not possible (or maybe even desirable) to establish a list of de nitive categories for selection criteria, they seem to be limited across study subjects, their identi cation could be interesting to promote a better comparison between studies and some efforts of this sort can be found in the literature (9). 2) there are only a few categories that could serve as a guide for inclusion or exclusion, since most of the categories (10 out of 18 or about 56%) were found either listed as inclusion or exclusion criteria or even as both in some cases; 3) in at least one third of the situations in which the same category was mentioned as inclusion and exclusion this could be avoided and in most cases indicate a certain confusion about the role of the criteria for the study; 4) excluding particularities of cervical cancer studies only two categories remained as inclusion only and one as exclusion only.…”
Section: Discussionmentioning
confidence: 99%
“…The reported number was in 15% of studies lower than the IQR and in 21% of studies higher. Inclusion (exclusion) criteria were not reported in 25% (31%) of studies (9). However, there is no clear differentiation between these criteria or even these differential functions in many clinical trials, even though a precise description of them is important not only to identify the homogeneity/heterogeneity of the population studied, but also to assess the very internal and external validity of the study and to identify which studies are actually comparable.…”
Section: Introductionmentioning
confidence: 99%
“…No difference was found among the groups of studies for exclusion criteria. In real-world practice, patients are not excluded from treatment 13 15 16 48…”
Section: Discussionmentioning
confidence: 99%